Sonoma Pharmaceuticals, Inc. — Director's Dealing 2012

Dec 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2012-12-06

Reporting Person: Alimi Hojabr (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-06	Common Stock	P	1000	$0.6256	Acquired	1012250	Direct
2012-12-06	Common Stock	P	1000	$0.6292	Acquired	1013250	Direct
2012-12-06	Common Stock	P	3000	$0.6329	Acquired	1016250	Direct
2012-12-06	Common Stock	P	4000	$0.6373	Acquired	1020250	Direct

Footnotes

F1: Mr. Alimi purchased these shares in the open market.

F2: Mr. Alimi beneficially owns these shares of common stock in joint ownership with his wife, Linda Alimi, with whom he shares voting and dispositive control.